| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Clearing the MIST (metabolites in safety testing) of time: The impact of duration of administration on drug metabolite toxicity
|
Smith, Dennis A.
|
|
2009
|
179 |
1 |
p. 60-67
8 p.
|
article
|
| 2 |
Dogma driven science, the need to establish a common base line
|
Smith, Dennis A.
|
|
2009
|
179 |
1 |
p. 68-70
3 p.
|
article
|
| 3 |
Editorial Board
|
|
|
2009
|
179 |
1 |
p. ii-
1 p.
|
article
|
| 4 |
Filling and mining the reactive metabolite target protein database
|
Hanzlik, Robert P.
|
|
2009
|
179 |
1 |
p. 38-44
7 p.
|
article
|
| 5 |
IFC Editorial Board
|
|
|
2009
|
179 |
1 |
p. CO2-
1 p.
|
article
|
| 6 |
Metabolism Comparative Cytotoxicity Assay (MCCA) and Cytotoxic Metabolic Pathway Identification Assay (CMPIA) with cryopreserved human hepatocytes for the evaluation of metabolism-based cytotoxicity in vitro: Proof-of-concept study with aflatoxin B1
|
Li, Albert P.
|
|
2009
|
179 |
1 |
p. 4-8
5 p.
|
article
|
| 7 |
Overview: Evaluation of metabolism-based drug toxicity in drug development
|
Li, Albert P.
|
|
2009
|
179 |
1 |
p. 1-3
3 p.
|
article
|
| 8 |
Recent advances in applications of liquid chromatography–tandem mass spectrometry to the analysis of reactive drug metabolites
|
Ma, Shuguang
|
|
2009
|
179 |
1 |
p. 25-37
13 p.
|
article
|
| 9 |
Safety testing of metabolites: Expectations and outcomes
|
Pang, K. Sandy
|
|
2009
|
179 |
1 |
p. 45-59
15 p.
|
article
|
| 10 |
Species-specific toxicity of diclofenac and troglitazone in primary human and rat hepatocytes
|
Lauer, Birthe
|
|
2009
|
179 |
1 |
p. 17-24
8 p.
|
article
|
| 11 |
Tissue slices for the evaluation of metabolism-based toxicity with the example of diclofenac
|
Vickers, Alison E.M.
|
|
2009
|
179 |
1 |
p. 9-16
8 p.
|
article
|
Journal description